Nathaniel Wang

Nathaniel Wang is an executive and founder with over 15 years of leadership experience in immunology and drug development in both biotech and pharma.

He is a pioneer and recognized expert in synthetic, self-replicating RNA technologies and their delivery, focusing on the development of immunotherapies for oncology, infectious disease, and other therapeutic areas.

Nathaniel has a strong background in business strategy, transactions, and corporate development, coupled with exceptional people leadership skills in various management structures and across global teams.

He is a scientist with numerous scientific publications and patents to his credit.

Nathaniel Wang holds a Doctor of Philosophy (Ph.D.) in Immunology from The Scripps Research Institute and a B.A. in Molecular and Cellular Biology from the University of California, Berkeley.

Currently, Nathaniel serves as the Chief Executive Officer and Co-Founder at Replicate Bioscience, Inc. He has previously held positions at various prestigious organizations, including The Janssen Pharmaceutical Companies of Johnson & Johnson, Synthetic Genomics, and Sangamo BioSciences, among others.